Antibiotic sensitivity testing
Results indicated a sensitivity pattern of antibiotics in the following order: Levofloxacin (87.5%), Ciprofloxacin (82.5%), Co-trimoxazole (77.5%), Amoxyclav (72.5%), Gentamicin (72.5%), Amikacin (67.5%), Tetracycline (42.5%), Cephalothin (42.5 %), Cefuroxime (37.5%), Azithromicin (25%) Ceftriaxone (72.5%), Cloxacillin (67.5%).
Verma et al., (2018) conducted a study to see the antibiotic sensitivity pattern in mastitis affected cows and results indicate 65.96% and 63.83% sensitivity for Ceftriaxone and Amoxicillin, respectively. The results of Antibiotic Sensitivity testing are depicted in Table 3 and Fig 1.
Isolation of Staphylococcus aureus
Among the total number of milk samples collected, 88.88% of the samples were confirmed to be
Staphylococcus organisms by virtue of growth of yellow coloured colonies on MSA plates. The colonies were aseptically picked and transferred to 50% glycerol stock solution for the purpose of storage. Mannitol Salt Agar (MSA) has been used since 1945 as a selective medium for the isolation of pathogenic
Staphylococci (Blair
et al., 1967; Chapman, 1945). So, it possibly indicates that some of the samples that were found positive for
Staphylococcus organism belonged to genus other than
Staphylococcus aureus (Sheilds and Tsang, 2006). The growth of yellow coloured colonies is depicted in Fig 2.
Polymerase chain reaction
Among the positive isolates of
Staphylococcus organisms that were subjected to
nuc gene amplification, 25% of the isolates were confirmed to be positive for
Staphylococcus aureus as indicated by PCR results. The positive
Staphylococcus organisms were also subjected to amplification of
mecA gene using PCR and results revealed the presence of
mec A gene in 12.5% of Staphylococcus isolates that were subjected to amplification of the concerned gene. Amplification of
mecA gene was done with the help of PCR using
mec A primer. The agarose gel electrophoresis of
mec A and
nuc gene PCR products are depicted in Fig 3.
Minimum inhibitory concentration
MIC
50 and MIC
90 for ceftriaxone against
Staphylococcus aureus were recorded to be 10.95 µg/ml and 87.5 µg/ml, respectively. Similarly, MIC
50 and MIC
90 of Cloxacillin were found to be 43.75 µg/mland 87.5 µg/ml, respectively against
Staphylococcus aureus. Current FDA Ceftriaxone breakpoints are <4 µg/ml (susceptible), 8 µg/ml (intermediate) and >16 µg/ml (resistant). The FDA Cloxacillin breakpoints are < 2µg/ml (Susceptible) and > 4µg/ml (Resistant). The MIC study for Cloxacillin was found to be 43.75 µg/ml - 87.5 µg/ml against
Staphylococcus aureus. The results of the present study suggest that the isolates of
S. aureus were resistant to Ceftriaxone which would involve a mechanism of PBP mutation. MIC values indicate resistance of
Staphylococcus aureus to both ceftriaxone and cloxacillin. However, study on a greater number of isolates is required to characterize the extent and type of resistance.